These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2552223)

  • 1. [Experiences with a "rapid test" in detecting antibodies to cytomegalovirus].
    Milbradt H
    Klin Wochenschr; 1989 Aug; 67(16):839-40. PubMed ID: 2552223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients.
    Chou SW; Scott KM
    J Clin Microbiol; 1988 Oct; 26(10):2116-9. PubMed ID: 2846638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a commercial latex agglutination test for detecting antibodies to cytomegalovirus in organ donors and transplant recipients.
    Gray JJ; Alvey B; Smith DJ; Wreghitt TG
    J Virol Methods; 1987 May; 16(1-2):13-9. PubMed ID: 3038936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four methods for screening of cytomegalovirus antibodies in normal donors and immunocompromised patients.
    de Ory F; León P; Domingo C; Garcia-Sáiz A; Pérez L; Echevarría JM
    Eur J Clin Microbiol; 1987 Aug; 6(4):402-5. PubMed ID: 2822396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CMV screening with the latex agglutination test in blood donors. Comparison between EIA and latex agglutination].
    Müller R; Milbradt H
    Beitr Infusionsther; 1990; 26():43-5. PubMed ID: 1703892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cytomegalovirus antibody with latex agglutination.
    Adler SP; McVoy M; Biro VG; Britt WJ; Hider P; Marshall D
    J Clin Microbiol; 1985 Jul; 22(1):68-70. PubMed ID: 2991330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cytomegalovirus antibodies in Thai blood donors.
    Kositanont U; Wasi C; Chandanayingyong D; Thongcharoen P
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):179-82. PubMed ID: 3000401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests.
    Grillner L
    J Virol Methods; 1987 Aug; 17(1-2):133-9. PubMed ID: 2822749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytomegalovirus diagnosis in blood donors and risk patients].
    Sibrowski W; Kühnl P; Kalmar G; Albert S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():37-9. PubMed ID: 1703874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latex agglutination test for cytomegalovirus antibody screening of transplant donors. Important aspects.
    Zbinden R; Decurtins M; Wunderli W
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):407-9. PubMed ID: 1322809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CMV antibody determination with two enzyme immunoassays in each case].
    Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytomegalovirus (CMV) infection: a frequent and life-threatening complication in heart transplant patients].
    Mohacsi P; Leonardi L; Waser M; Lüthy A; Laske A; Turina M; Gallino A
    Ther Umsch; 1990 Feb; 47(2):157-63. PubMed ID: 2156344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cytomegalovirus antibody in platelet concentrates by fluorescence immunoassay and latex agglutination.
    DePalma L; Criss VR; Sullivan MT; Leitman SF; Williams AE; Luban NL
    Transfusion; 1991; 31(3):245-8. PubMed ID: 1848376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus testing: antibody determinations and virus cultures with recommendations for use.
    Schultz DA; Chandler S
    J Clin Lab Anal; 1991; 5(1):69-73. PubMed ID: 1847971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of latex agglutination and dot immunobinding assay for the detection of cytomegalovirus antibody.
    Wilson MT; Sautter RL; LeBar WD; Mervak TR
    Diagn Microbiol Infect Dis; 1990; 13(4):303-6. PubMed ID: 1963835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepant results with a latex agglutination test in the assessment of cytomegalovirus antibody status of cardiac transplant donors.
    Freeman R; Gould FK; McMaster A
    Zentralbl Bakteriol; 1991 Jan; 274(4):537-42. PubMed ID: 1650557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of bone marrow and kidney transplant donors and recipients for cytomegalovirus antibody by commercial latex agglutination or competitive enzyme-linked immunosorbent assays.
    Morris DJ; Klapper PE; Crosdale E; White J
    J Virol Methods; 1990 Dec; 30(3):339-42. PubMed ID: 1964947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two enzyme immunoassays and two latex agglutination assays for detection of cytomegalovirus antibody.
    Doern GV; Robbie L; Marrama L
    Diagn Microbiol Infect Dis; 1994 Oct; 20(2):109-12. PubMed ID: 7867303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.